ArticleBreast cancer research and treatment2019

Strong CD8+ lymphocyte infiltration in combination with expression of HLA class I is associated with better tumor control in breast cancer patients treated with neoadjuvant chemotherapy.

A F de Groot et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.